In Telangana state, vaccines in opposition to human papillomavirus (HPV) will likely be administered freed from cost to ladies aged 14 and 15. Photographs are used for consultant functions solely. |Photograph supplied by: GETTY IMAGES
Telangana state is gearing as much as launch a state-wide human papillomavirus (HPV) vaccination program aimed toward defending adolescent women from cervical most cancers. A senior well being official stated the state has accomplished logistical preparations, together with coaching well being employees and stockpiling vaccines, and is awaiting formal approval from the federal authorities. The rollout is predicted to start across the finish of February.
As a part of this effort, the state authorities has procured 460,000 doses of quadrivalent Gardasil 4 vaccine. The vaccine will likely be administered freed from cost to ladies aged 14 and 15 at major well being facilities (PHCs) and different public well being services throughout Telangana.
Safety in opposition to the 4 most typical cancer-causing strains
The quadrivalent HPV vaccine gives safety in opposition to the 4 most typical cancer-causing strains of the virus. Well being officers stated the majority vaccine procurement is a part of the state’s technique to deal with the rising burden of cervical most cancers. Vaccines sometimes price between Rs 2,000 and Rs 4,000 per dose within the personal sector, making free entry to the general public an essential intervention.
To make sure clean implementation on the grassroots stage, the well being division has educated 1,200 medical personnel, 2,600 MLHPs, 1,850 supervisors, 7,000 ANMs and a couple of,000 different workers from throughout the state.
Cervical most cancers incidence
The deliberate rollout comes within the backdrop of a gentle rise in cervical most cancers instances and associated deaths in Telangana. In line with knowledge shared within the Lok Sabha by Anupriya Patel, Minister of State for Well being and Household Welfare on February 13, 2026, the state recorded 3,169 cervical most cancers instances in 2021, which rose to three,185 in 2022, 3,201 in 2023, 3,217 in 2024 and three,233 in 2025.
The mortality price from cervical most cancers can be on the rise. In line with the information, 1,711 deaths have been reported in Telangana in 2021, adopted by 1,720 in 2022, 1,729 in 2023, 1,737 in 2024 and 1,746 in 2025.
| 12 months | Cervical most cancers instances in Telangana | Mortality price from cervical most cancers |
| 2021 | 3,169 | 1,711 |
| 2022 | 3,185 | 1,720 |
| 2023 | 3,201 | 1,729 |
| 2024 | 3,217 | 1,737 |
| 2025 | 3,233 | 1,746 |
“The HPV vaccination program is predicted to play an essential function in decreasing future incidence of cervical most cancers by stopping an infection early, particularly in adolescent women,” the official added.
